中华放射医学与防护杂志
中華放射醫學與防護雜誌
중화방사의학여방호잡지
Chinese Journal of Radiological Medicine and Protection
2012年
6期
621-625
,共5页
任正婷%崔迪%任晔%戴卓捷%苏晓明%樊晶晶%申玉龙%马慧珍%王宗烨
任正婷%崔迪%任曄%戴卓捷%囌曉明%樊晶晶%申玉龍%馬慧珍%王宗燁
임정정%최적%임엽%대탁첩%소효명%번정정%신옥룡%마혜진%왕종엽
立体定向放疗%非小细胞肺癌%局部控制率%总生存率%生存质量
立體定嚮放療%非小細胞肺癌%跼部控製率%總生存率%生存質量
입체정향방료%비소세포폐암%국부공제솔%총생존솔%생존질량
Stereotactic radiotherapy (SBRT)%Non-small-cell lung cancer(NSCLC)%Local control rate%Overall survival%Quality of life
目的 探讨伽玛刀立体定向放射治疗早期非小细胞肺癌患者的疗效及生存质量分析.方法 20例非手术治疗的早期非小细胞肺癌患者,中位年龄76岁.Ⅰ期患者10例,Ⅱ期10例.根据患者的具体状况,给予伽玛刀分次立体定向放疗(SBRT)3~6 Gy×8~15次,2~3周完成,采用50%等剂量曲线包绕95%以上PTV,边缘剂量39 ~ 56 Gy,中心剂量78 ~ 112 Gy.在入院后、治疗结束后1、3、6和12个月至病情进展或者死亡,根据EORTC QLQ-LC43中相关变量对患者进行系统评价,比较放疗前后生存质量变化.结果 中位随访时间为24个月.20例患者治疗后6个月有效率为80%,原发病灶完全缓解率为35%.1、2、3年局部控制率分别为100%、95%、95%;l、2、3年总生存率分别为95%、80%、50%;1、2、3年无进展生存率为85%、64%、33%.3年失败率为20%,5%为PTV内进展.治疗期间无3级及以上急性不良反应发生,15%的患者出现1~2级放射性肺炎.年龄、性别、有无病理诊断等临床因素与患者生存相关性较弱(P>0.05).生存质量中情绪功能明显改善,差异有统计学意义(P<0.05);呼吸困难和咳嗽有不同程度改善,躯体功能、疲倦、食欲减退和失眠无加重,差异均无统计学意义.结论 SBRT对于老年患者取得了良好的结果,局部控制率高,不良反应作用小,生存率尚可,能明显改善情绪功能及患者生存质量.
目的 探討伽瑪刀立體定嚮放射治療早期非小細胞肺癌患者的療效及生存質量分析.方法 20例非手術治療的早期非小細胞肺癌患者,中位年齡76歲.Ⅰ期患者10例,Ⅱ期10例.根據患者的具體狀況,給予伽瑪刀分次立體定嚮放療(SBRT)3~6 Gy×8~15次,2~3週完成,採用50%等劑量麯線包繞95%以上PTV,邊緣劑量39 ~ 56 Gy,中心劑量78 ~ 112 Gy.在入院後、治療結束後1、3、6和12箇月至病情進展或者死亡,根據EORTC QLQ-LC43中相關變量對患者進行繫統評價,比較放療前後生存質量變化.結果 中位隨訪時間為24箇月.20例患者治療後6箇月有效率為80%,原髮病竈完全緩解率為35%.1、2、3年跼部控製率分彆為100%、95%、95%;l、2、3年總生存率分彆為95%、80%、50%;1、2、3年無進展生存率為85%、64%、33%.3年失敗率為20%,5%為PTV內進展.治療期間無3級及以上急性不良反應髮生,15%的患者齣現1~2級放射性肺炎.年齡、性彆、有無病理診斷等臨床因素與患者生存相關性較弱(P>0.05).生存質量中情緒功能明顯改善,差異有統計學意義(P<0.05);呼吸睏難和咳嗽有不同程度改善,軀體功能、疲倦、食欲減退和失眠無加重,差異均無統計學意義.結論 SBRT對于老年患者取得瞭良好的結果,跼部控製率高,不良反應作用小,生存率尚可,能明顯改善情緒功能及患者生存質量.
목적 탐토가마도입체정향방사치료조기비소세포폐암환자적료효급생존질량분석.방법 20례비수술치료적조기비소세포폐암환자,중위년령76세.Ⅰ기환자10례,Ⅱ기10례.근거환자적구체상황,급여가마도분차입체정향방료(SBRT)3~6 Gy×8~15차,2~3주완성,채용50%등제량곡선포요95%이상PTV,변연제량39 ~ 56 Gy,중심제량78 ~ 112 Gy.재입원후、치료결속후1、3、6화12개월지병정진전혹자사망,근거EORTC QLQ-LC43중상관변량대환자진행계통평개,비교방료전후생존질량변화.결과 중위수방시간위24개월.20례환자치료후6개월유효솔위80%,원발병조완전완해솔위35%.1、2、3년국부공제솔분별위100%、95%、95%;l、2、3년총생존솔분별위95%、80%、50%;1、2、3년무진전생존솔위85%、64%、33%.3년실패솔위20%,5%위PTV내진전.치료기간무3급급이상급성불량반응발생,15%적환자출현1~2급방사성폐염.년령、성별、유무병리진단등림상인소여환자생존상관성교약(P>0.05).생존질량중정서공능명현개선,차이유통계학의의(P<0.05);호흡곤난화해수유불동정도개선,구체공능、피권、식욕감퇴화실면무가중,차이균무통계학의의.결론 SBRT대우노년환자취득료량호적결과,국부공제솔고,불량반응작용소,생존솔상가,능명현개선정서공능급환자생존질량.
Objective To evaluate the therapeutic efficacy of stereotactic body radiotherapy (SBRT) with gamma knife on stage Ⅰ-Ⅱ non-small-cell lung cancer(NSCLC)and the quality of life of the patients undergoing this therapy.Methods Twenty NSCLC patients with the median age of 76,10 at stage Ⅰ and 10 at stage Ⅱ who were unable or unwilling to undergo surgery were given SBRT with gamma knife at the doses of 3-6 Gy in 8-15 fractions,finished within 2 to 3 weeks.The prescription isodose line was 50%,the marginal dose was 39-56 Gy,the central dose was 78-112 Gy,and the total biologically effective dose was 51-83 Gy.The patients were observed after admission and followed up by chest CT 1,3,6,and 12 months after treatment until progressive disease or death.EORTC QLQ-LC43 questionnaire was used to investigate the changes in quality of life.Results The 20 patients were followed up for 24 (12-46) months.At six months after the treatment,the overall response rate was 80%,and the complete response rate was 35%.The 1,2 and 3-year local control rates were 100%,95% and 95%,respectively.The 1,2 and 3-year overall survival rates were 95%,80% and 50% respectively; The 1,2,and 3-year progression free survival rates were 85%,64% and 33%,respectively.The failure rate was 20% and the rate of progress within the planning target volume was 5%.No acute toxicity at grade 3 and over occurred in any patient during the treatment.15% of the patients developed grade 1-2 radiation pneumonia.Age,gender,pathologic index or not were weakly correlated with the overall survival.The emotional function was improved significantly after treatment (P < 0.05),dyspnea and cough were improved at different degrees,however,not significantly.There were no significant changes in the physical function and symptoms,such as fatigue,lack of appetite,insomnia,etc.Conclusions Significantly improving the motional function and maintaining the quality of life,SBRT with gamma knife is effective for elderly NSCLC patients with high local control rate fair overall survival rate and few side effects.